Trial of Bortezomib, Cytarabine, and Dexamethasone in Mantle Cell Lymphoma

Clinical trial NCT02840539 · COMPLETED

Trial details

NCT number: NCT02840539
Sponsor: Seoul National University Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Mantle Cell Lymphoma

Start date: 2016-10-11
Primary completion: 2021-03-31
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.